Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Other Working Capital Changes (2022 - 2025)

Exagen (XGN) has disclosed Other Working Capital Changes for 4 consecutive years, with -$288000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 70.49% year-over-year to -$288000.0, compared with a TTM value of -$1.1 million through Dec 2025, down 12.3%, and an annual FY2025 reading of -$1.1 million, down 12.3% over the prior year.
  • Other Working Capital Changes was -$288000.0 for Q4 2025 at Exagen, up from -$1.1 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $546000.0 in Q2 2025 and bottomed at -$1.1 million in Q3 2025.
  • Average Other Working Capital Changes over 4 years is -$302769.2, with a median of -$250000.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes tumbled 301.65% in 2024, then soared 70.49% in 2025.
  • Year by year, Other Working Capital Changes stood at -$241000.0 in 2022, then decreased by 0.83% to -$243000.0 in 2023, then crashed by 301.65% to -$976000.0 in 2024, then skyrocketed by 70.49% to -$288000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for XGN at -$288000.0 in Q4 2025, -$1.1 million in Q3 2025, and $546000.0 in Q2 2025.